Lenvatinib 10 mg Capsule is a targeted anti-cancer medicine used in the treatment of thyroid cancer, liver cancer (Hepatocellular Carcinoma), and renal cell carcinoma (kidney cancer). It works by blocking cancer cell growth and tumor blood supply, slowing tumor progression.
It is classified as a tyrosine kinase inhibitor (TKI) and is commonly prescribed in advanced or metastatic cancer cases.
⚙️ Mechanism of Action
Lenvatinib inhibits multiple receptor tyrosine kinases, including:
-
VEGFR (Vascular Endothelial Growth Factor Receptors)
-
FGFR (Fibroblast Growth Factor Receptors)
-
PDGFR
This results in:
-
Reduced tumor blood vessel formation
-
Slowed cancer cell growth
-
Suppressed tumor progression
-
Improved progression-free survival
🩺 Uses of Lenvatinib 10 mg Capsule
-
Differentiated thyroid cancer (DTC)
-
Hepatocellular carcinoma (Liver cancer)
-
Renal cell carcinoma (Kidney cancer)
-
Advanced solid tumors (as prescribed)
💡 Benefits
-
Targets tumor growth pathways
-
Reduces cancer spread
-
Improves survival outcomes
-
Oral targeted therapy (non-injectable)
-
Suitable for long-term cancer management
📌 Dosage & Administration
-
Dosage depends on cancer type & patient condition
-
Taken once daily with or without food
-
Swallow capsule whole with water
-
Follow oncologist-prescribed schedule strictly
⚠ Do not stop or modify dose without medical advice.
⚠️ Possible Side Effects
-
High blood pressure
-
Fatigue
-
Diarrhea
-
Decreased appetite
-
Hand-foot syndrome
-
Weight loss
-
Liver function changes
-
Protein in urine
🚫 Precautions & Warnings
-
Prescription-only cancer medicine
-
Monitor blood pressure & liver function
-
Avoid pregnancy & breastfeeding
-
Use caution in heart, liver, or kidney disease
-
Regular oncology follow-up required
🏥 Storage Instructions
-
Store below 25°C
-
Keep away from heat and moisture
-
Keep out of reach of children
📦 Packaging Details
-
Strength: 10 mg
-
Dosage Form: Capsule
-
Brand: Lenvaliz™ 10
-
Pack Size: 30 Capsules (Bottle)
-
Route: Oral Use
Reviews
There are no reviews yet.